Critical review finds cannabinoid evidence for fibromyalgia pain is promising but methodologically limited
A critical review of five recent studies involving 827 participants found that cannabinoids showed potential for fibromyalgia pain relief, but methodological problems prevent definitive conclusions.
Quick Facts
What This Study Found
Five studies using six different cannabis treatments (including nabilone, dronabinol, Bedrocan, Bediol, CBD, and medical cannabis) showed generally favorable patient-reported outcomes for fibromyalgia pain. However, the review identified significant methodological limitations including issues with generalizability and validity.
Key Numbers
5 studies identified involving 827 participants, using 6 different cannabinoid treatments. Timeframe: 2015-2019.
How They Did This
Systematic search following PRISMA guidelines of PubMed and Medline databases (2015-2019) for all study designs examining cannabis preparations for fibromyalgia, excluding prior systematic reviews and meta-analyses.
Why This Research Matters
Fibromyalgia affects 5-7% of the global population and responds poorly to traditional pain treatments. Cannabinoids represent a potential alternative, but the evidence base needs strengthening.
The Bigger Picture
Despite growing patient interest in cannabinoids for fibromyalgia, the research has not kept pace. The small number of recent studies and their methodological issues highlight a gap between patient demand and scientific evidence.
What This Study Doesn't Tell Us
Only 5 studies met inclusion criteria; significant methodological problems identified in included studies; heterogeneous treatments and outcomes make comparison difficult; the review itself is limited by the underlying evidence quality.
Questions This Raises
- ?Which cannabinoid formulations are most effective for fibromyalgia?
- ?What dosing protocols would be optimal?
- ?Are certain fibromyalgia subtypes more responsive to cannabinoid treatment?
Trust & Context
- Key Stat:
- Only 5 studies (827 participants) published 2015-2019 met inclusion criteria
- Evidence Grade:
- Systematic review of a small number of studies with identified methodological limitations.
- Study Age:
- Published in 2020.
- Original Title:
- Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015-2019).
- Published In:
- Journal of cannabis research, 2(1), 19 (2020)
- Authors:
- Cameron, Erinn C, Hemingway, Samantha L
- Database ID:
- RTHC-02447
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Do cannabinoids work for fibromyalgia?
The reviewed studies superficially suggest cannabinoids may help with fibromyalgia pain, but the researchers identified serious methodological problems that prevent a definitive answer. More rigorous research is needed.
Why is the evidence so limited for such a common condition?
Fibromyalgia affects 5-7% of the global population, but cannabinoid research for this condition faces regulatory barriers, difficulty standardizing treatments, and the challenge of conducting blinded trials with cannabis products. Only 5 qualifying studies were published in a 4-year period.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02447APA
Cameron, Erinn C; Hemingway, Samantha L. (2020). Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015-2019).. Journal of cannabis research, 2(1), 19. https://doi.org/10.1186/s42238-020-00024-2
MLA
Cameron, Erinn C, et al. "Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015-2019).." Journal of cannabis research, 2020. https://doi.org/10.1186/s42238-020-00024-2
RethinkTHC
RethinkTHC Research Database. "Cannabinoids for fibromyalgia pain: a critical review of rec..." RTHC-02447. Retrieved from https://rethinkthc.com/research/cameron-2020-cannabinoids-for-fibromyalgia-pain
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.